Radiation therapy of ceruminous gland carcinomas in dogs and cats.

Alain P Theon, P. Y. Barthez, B. R. Madewell, Stephen M Griffey

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Nine dogs and 9 cats with ceruminous gland carcinoma were evaluated to determine whether they would receive radiation therapy. Tissue samples were reviewed to confirm the diagnosis and to assess completeness of resection in animals that had undergone surgery. Seven animals were excluded because surgical excision was determined histologically to have been complete (5) or because the owners did not wish to pursue treatment, because of advanced disease (2). The remaining 6 cats and 5 dogs, 6 of which had previously undergone surgery, were included in the study. The radiation therapy dose was 48 Gy, given in 12 fractions over 4 weeks. The product-limit estimate of mean progression-free survival time was 39.5 months. The estimate of 1-year progression-free survival rate was 56%. The tumor recurred in 4 animals, and metastases were observed in 3 animals. Radiation therapy was found to be safe and effective.

Original languageEnglish (US)
Pages (from-to)566-569
Number of pages4
JournalJournal of the American Veterinary Medical Association
Volume205
Issue number4
StatePublished - Aug 15 1994

Fingerprint

radiotherapy
carcinoma
Cats
Radiotherapy
Dogs
cats
Carcinoma
dogs
Disease-Free Survival
animals
surgery
excision
resection
metastasis
survival rate
Neoplasm Metastasis
neoplasms
dosage
Neoplasms
sampling

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Radiation therapy of ceruminous gland carcinomas in dogs and cats. / Theon, Alain P; Barthez, P. Y.; Madewell, B. R.; Griffey, Stephen M.

In: Journal of the American Veterinary Medical Association, Vol. 205, No. 4, 15.08.1994, p. 566-569.

Research output: Contribution to journalArticle

@article{1b2abbe7d9914f9393f9cce310c2e10b,
title = "Radiation therapy of ceruminous gland carcinomas in dogs and cats.",
abstract = "Nine dogs and 9 cats with ceruminous gland carcinoma were evaluated to determine whether they would receive radiation therapy. Tissue samples were reviewed to confirm the diagnosis and to assess completeness of resection in animals that had undergone surgery. Seven animals were excluded because surgical excision was determined histologically to have been complete (5) or because the owners did not wish to pursue treatment, because of advanced disease (2). The remaining 6 cats and 5 dogs, 6 of which had previously undergone surgery, were included in the study. The radiation therapy dose was 48 Gy, given in 12 fractions over 4 weeks. The product-limit estimate of mean progression-free survival time was 39.5 months. The estimate of 1-year progression-free survival rate was 56{\%}. The tumor recurred in 4 animals, and metastases were observed in 3 animals. Radiation therapy was found to be safe and effective.",
author = "Theon, {Alain P} and Barthez, {P. Y.} and Madewell, {B. R.} and Griffey, {Stephen M}",
year = "1994",
month = "8",
day = "15",
language = "English (US)",
volume = "205",
pages = "566--569",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "4",

}

TY - JOUR

T1 - Radiation therapy of ceruminous gland carcinomas in dogs and cats.

AU - Theon, Alain P

AU - Barthez, P. Y.

AU - Madewell, B. R.

AU - Griffey, Stephen M

PY - 1994/8/15

Y1 - 1994/8/15

N2 - Nine dogs and 9 cats with ceruminous gland carcinoma were evaluated to determine whether they would receive radiation therapy. Tissue samples were reviewed to confirm the diagnosis and to assess completeness of resection in animals that had undergone surgery. Seven animals were excluded because surgical excision was determined histologically to have been complete (5) or because the owners did not wish to pursue treatment, because of advanced disease (2). The remaining 6 cats and 5 dogs, 6 of which had previously undergone surgery, were included in the study. The radiation therapy dose was 48 Gy, given in 12 fractions over 4 weeks. The product-limit estimate of mean progression-free survival time was 39.5 months. The estimate of 1-year progression-free survival rate was 56%. The tumor recurred in 4 animals, and metastases were observed in 3 animals. Radiation therapy was found to be safe and effective.

AB - Nine dogs and 9 cats with ceruminous gland carcinoma were evaluated to determine whether they would receive radiation therapy. Tissue samples were reviewed to confirm the diagnosis and to assess completeness of resection in animals that had undergone surgery. Seven animals were excluded because surgical excision was determined histologically to have been complete (5) or because the owners did not wish to pursue treatment, because of advanced disease (2). The remaining 6 cats and 5 dogs, 6 of which had previously undergone surgery, were included in the study. The radiation therapy dose was 48 Gy, given in 12 fractions over 4 weeks. The product-limit estimate of mean progression-free survival time was 39.5 months. The estimate of 1-year progression-free survival rate was 56%. The tumor recurred in 4 animals, and metastases were observed in 3 animals. Radiation therapy was found to be safe and effective.

UR - http://www.scopus.com/inward/record.url?scp=0028774087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028774087&partnerID=8YFLogxK

M3 - Article

C2 - 7961091

AN - SCOPUS:0028774087

VL - 205

SP - 566

EP - 569

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 4

ER -